Aarti Pharmalabs Ltd.
AARTIPHARM Share PricePharmaceuticals & Drugs
₹723.45
15.7 (2.2%)
As on December 4, 2025
Exchange Scrips: BSE543748NSEAARTIPHARMISININE0LRU01027
Market Cap ₹ 6,529 Cr
P/E Ratio 24.07
Dividend Yield 0.14 %
Performance
Market performance
Open711
High725.85
Volumes1,55,064
Prev723.45
Low703.75
As on2025-12-04
Historical performance
1 Year High971
3 Year High971
5 Year High971
1 Year Low557.05
3 Year Low234.8
5 Year Low234.8
Fundamentals
Company Valuation
Market Cap (₹Cr)
6,529
Face Value (₹)
5
P/E Ratio
24.07
Dividend Yield
0.14 %
Investment Returns
1 Year
10.5%
3 Years
N/A
5 Years
N/A
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 706.33 | Bullish |
| 10-DMA | 699.62 | Bullish |
| 20-DMA | 724.03 | Bearish |
| 50-DMA | 793.63 | Bearish |
| 100-DMA | 841.23 | Bearish |
| 200-DMA | 819.24 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 48 | 48 | 48 | 45 | 46 |
| Foreign Investors | 1 | 1 | 1 | 1 | 1 |
| Domestic Investors | 47 | 47 | 47 | 44 | 45 |
| Public Investors | 190607 | 186991 | 196266 | 185066 | 185390 |
| Government | 1 | 1 | 1 | 1 | 1 |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 24.07.
- 3Y Stock Price CAGR of the stock is 58.4.
- The stock has a beta of 1.1.
- In the last financial year, the company had an EBITDA of ₹4745 Million.
- The company generated revenue of ₹21151 Million in the previous financial year.
Aarti Pharmalabs Ltd.
723.4515.7 (2.2%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1122585.2
No. of Shares: 1552 (Approx)
Performance:12.3%
P/L: ₹122585.2
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
